Yi Bei

887 total citations
7 papers, 76 citations indexed

About

Yi Bei is a scholar working on Molecular Biology, Surgery and Neurology. According to data from OpenAlex, Yi Bei has authored 7 papers receiving a total of 76 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 1 paper in Surgery and 1 paper in Neurology. Recurrent topics in Yi Bei's work include Ubiquitin and proteasome pathways (2 papers), RNA Research and Splicing (2 papers) and Cholesterol and Lipid Metabolism (1 paper). Yi Bei is often cited by papers focused on Ubiquitin and proteasome pathways (2 papers), RNA Research and Splicing (2 papers) and Cholesterol and Lipid Metabolism (1 paper). Yi Bei collaborates with scholars based in China, Germany and Russia. Yi Bei's co-authors include Xingxin Li, Xi Peng, Xi Huang, Jianbin Chen, Angelika Eggert, Johannes H. Schulte, Heathcliff Dorado García, Anton G. Henssen, Alex Kentsis and Joern Toedling and has published in prestigious journals such as Cancer Letters, Frontiers in Pharmacology and JCI Insight.

In The Last Decade

Yi Bei

7 papers receiving 76 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yi Bei China	4	61	15	15	8	7	7	76
Harshal Shah United States	3	63 1.0×	4 0.3×	10 0.7×	10 1.3×	12 1.7×	6	82
Apurva M. Hegde United States	4	62 1.0×	10 0.7×	15 1.0×	2 0.3×	18 2.6×	5	89
Bridget E. Begg United States	5	152 2.5×	9 0.6×	25 1.7×	3 0.4×	5 0.7×	6	172
Beth A. Miller United States	4	56 0.9×	6 0.4×	6 0.4×	6 0.8×	9 1.3×	5	81
Sunny J. Jones United States	4	95 1.6×	30 2.0×	23 1.5×	16 2.0×	13 1.9×	5	124
Yilun Ma United States	5	38 0.6×	14 0.9×	21 1.4×	5 0.6×	7 1.0×	9	89
Somaieh Hedayat United Kingdom	5	85 1.4×	18 1.2×	26 1.7×	7 0.9×	19 2.7×	7	119
Yinfei Tan United States	3	58 1.0×	7 0.5×	23 1.5×	5 0.6×	23 3.3×	3	98
Camilla Borges Ferreira Gomes United States	5	39 0.6×	16 1.1×	18 1.2×	4 0.5×	21 3.0×	5	70
Daniel Hüebschmann Germany	3	27 0.4×	4 0.3×	14 0.9×	15 1.9×	12 1.7×	3	49

Countries citing papers authored by Yi Bei

Since Specialization

Citations

This map shows the geographic impact of Yi Bei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Bei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Bei more than expected).

Fields of papers citing papers by Yi Bei

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yi Bei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Bei. The network helps show where Yi Bei may publish in the future.

Co-authorship network of co-authors of Yi Bei

This figure shows the co-authorship network connecting the top 25 collaborators of Yi Bei. A scholar is included among the top collaborators of Yi Bei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yi Bei. Yi Bei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Chen, Tianyu, Xiang Li, Min Lin, et al.. (2025). SREBP2 as a central player in cancer progression: potential for targeted therapeutics. Frontiers in Pharmacology. 16. 1535691–1535691. 1 indexed citations

2.

Zhang, Man, et al.. (2024). Emerging role of SENP1 in tumorigenesis and cancer therapy. Frontiers in Pharmacology. 15. 1354323–1354323. 2 indexed citations

3.

Lindner, Sven, Yi Bei, Heathcliff Dorado García, et al.. (2019). Synergistic activity of BET inhibitor MK-8628 and PLK inhibitor Volasertib in preclinical models of medulloblastoma. Cancer Letters. 445. 24–33. 20 indexed citations

4.

MacArthur, Ian C., Yi Bei, Heathcliff Dorado García, et al.. (2019). Prohibitin promotes dedifferentiation and is a potential therapeutic target in neuroblastoma. JCI Insight. 4(10). 17 indexed citations

5.

Li, Xingxin, et al.. (2018). Knockdown of NUPR1 inhibits the growth of U266 and RPMI8226 multiple myeloma cell lines via activating PTEN and caspase activation‑dependent apoptosis. Oncology Reports. 40(3). 1487–1494. 25 indexed citations

6.

Bei, Yi, et al.. (2017). [Knockdown of nuclear protein 1 (NUPR1) gene inhibits proliferation and promotes apoptosis of human multiple myeloma U266 cells].. PubMed. 33(9). 1240–1246. 10 indexed citations

7.

Bei, Yi. (1993). Clinical observations on the treatment of 98 cases of peptic ulcer by massage.. PubMed. 13(1). 50–1. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact